（文章来源：证券时报网） | 代码 | 简称 | 今日涨跌幅（%） | 今日换手率（%） | 主力资金流量（万元） | | --- | --- | --- | --- | --- | | 601288 | 农业银行 | 1.47 | 0.16 | 35895.65 | | 600036 | 招商银行 | 0.63 | 0.35 | 22595.49 | | 601398 | 工商银行 | 0.81 | 0.14 | 16467.76 | | 000001 | 平安银行 | 1.22 | 0.88 | 14568.44 | | 601988 | 中国银行 | 0.73 | 0.14 | 10610.18 | | 600000 | 浦发银行 | 0.70 | 0.24 | 9200.76 | | 600016 | 民生银行 | -0.20 | 0.87 | 9113.05 | | 601658 | 邮储银行 | 1.43 | 0.49 | 7782.41 | | 600919 | 江苏银行 | 1.24 | 0.70 | 6605.62 | | 601665 | 齐鲁银行 | -0.48 | 1.30 | 553 ...

金融界消息 截至2025年7月30日收盘，畅联股份（603648）报收于11.55元，上涨3.59%，换手率 6.09%，成交量22.05万手，成交金额2.54亿元。 天眼查商业履历信息显示，上海畅联国际物流股份有限公司，成立于2001年，位于上海市，是一家以从 事装卸搬运和仓储业为主的企业。企业注册资本36241.28万人民币，实缴资本21000万人民币。公司法 定代表人为徐峰。 通过天眼查大数据分析，上海畅联国际物流股份有限公司共对外投资了35家企业，参与招投标项目41 次，知识产权方面有商标信息92条，专利信息50条，此外企业还拥有行政许可344个。 来源：金融界 资金流向方面，今日主力资金净流入1798.74万元，占比成交额7.08%。其中，超大单净流入1714.83万 元、占成交额6.75%，大单净流入83.91万元、占成交额0.33%，中单净流出流出411.96万元、占成交额 1.62%，小单净流出1386.78万元、占成交额5.46%。 畅联股份最新一期业绩显示，截至2025一季报，公司营业总收入3.48亿元、同比减少17.63%，归属净利 润3169.38万元，同比减少21.78%，扣非净利润 ...

天眼查商业履历信息显示，凯撒同盛发展股份有限公司，成立于1996年，位于三亚市，是一家以从事新 闻和出版业为主的企业。企业注册资本80300.0258万人民币，实缴资本28831万人民币。公司法定代表 人为迟永杰。 通过天眼查大数据分析，凯撒同盛发展股份有限公司共对外投资了25家企业，参与招投标项目7次，知 识产权方面有商标信息4条，此外企业还拥有行政许可7个。 资金流向方面，今日主力资金净流入2.70亿元，占比成交额25.24%。其中，超大单净流入2.56亿元、占 成交额23.94%，大单净流入1391.92万元、占成交额1.3%，中单净流出流出12227.07万元、占成交额 11.43%，小单净流出14779.24万元、占成交额13.81%。 凯撒旅业最新一期业绩显示，截至2025一季报，公司营业总收入1.41亿元、同比减少12.60%，归属净利 润454.16万元，同比增长68.20%，扣非净利润524.41万元，同比减少1154.09%，流动比率1.809、速动比 率1.794、资产负债率49.92%。 金融界消息 截至2025年7月30日收盘，凯撒旅业（000796）报收于5.68元，上涨10.08 ...

Group 1 - The stock price of Fengyuan Pharmaceutical closed at 7.50 yuan on July 29, 2025, down 1.45% from the previous trading day, with a trading range of 8.94% [1] - The company is primarily engaged in the research, production, and sales of chemical raw materials and formulations, covering various therapeutic areas including antipyretic analgesics, antibiotics, and vitamins [1] - As a key enterprise in the pharmaceutical industry of Anhui Province, Fengyuan Pharmaceutical's business involves multiple segments including raw materials, formulations, and pharmaceutical commerce [1] Group 2 - On July 29, the stock experienced significant volatility, with a drop of over 2% within 5 minutes around 9:35 AM, followed by a rebound of over 2% shortly after at 9:41 AM, indicating active market trading [1] - The net outflow of main funds was 21.79 million yuan, accounting for 0.64% of the circulating market value, suggesting a certain degree of capital withdrawal [1]

Group 1 - The core viewpoint of the news is that Parker New Materials (605123) experienced a slight decline in stock price and a notable outflow of main funds, indicating potential investor concerns [1] - As of July 29, 2025, Parker New Materials' stock closed at 74.55 yuan, down 1.39%, with a turnover rate of 2.65% and a trading volume of 32,100 hands, amounting to 237 million yuan [1] - The latest quarterly report shows total operating revenue of 772 million yuan, a year-on-year increase of 2.95%, and a net profit attributable to shareholders of 76.62 million yuan, up 5.55% year-on-year [1] Group 2 - The company has a current ratio of 2.091, a quick ratio of 1.665, and a debt-to-asset ratio of 39.23%, indicating a relatively healthy liquidity position [1] - Parker New Materials has invested in 4 companies and participated in 599 bidding projects, showcasing its active engagement in the market [2] - The company holds 5 trademark registrations and 232 patents, along with 88 administrative licenses, reflecting its commitment to innovation and compliance [2]

天眼查商业履历信息显示，濮阳濮耐高温材料(集团)股份有限公司，成立于2002年，位于濮阳市，是一 家以从事非金属矿物制品业为主的企业。企业注册资本101041.2086万人民币，实缴资本33179.9997万人 民币。公司法定代表人为刘百宽。 通过天眼查大数据分析，濮阳濮耐高温材料(集团)股份有限公司共对外投资了28家企业，参与招投标项 目507次，知识产权方面有商标信息142条，专利信息260条，此外企业还拥有行政许可92个。 来源：金融界 金融界消息 截至2025年7月29日收盘，濮耐股份（002225）报收于6.73元，下跌0.3%，换手率13.42%， 成交量110.75万手，成交金额7.69亿元。 资金流向方面，今日主力资金净流出2955.45万元，占比成交额3.84%。其中，超大单净流出2362.72万 元、占成交额3.07%，大单净流出592.73万元、占成交额0.77%，中单净流出流出5212.01万元、占成交 额6.78%，小单净流入8167.45万元、占成交额10.62%。 濮耐股份最新一期业绩显示，截至2025一季报，公司营业总收入13.40亿元、同比增长3.17%，归属净利 润5487 ...

Group 1 - The core viewpoint of the news is that Rongda Photoelectric (300576) has shown a mixed performance in its latest financial results, with revenue growth but a decline in net profit [1] - As of July 29, 2025, the company's stock closed at 38.27 yuan, down 0.65%, with a turnover rate of 5.85% and a trading volume of 136,100 lots, amounting to 523 million yuan [1] - The latest quarterly report indicates total operating revenue of 242 million yuan, an 18.19% year-on-year increase, while net profit attributable to shareholders decreased by 4.49% to 34.61 million yuan [1] Group 2 - The company has a current ratio of 3.389, a quick ratio of 3.045, and a debt-to-asset ratio of 19.72%, indicating strong liquidity and low leverage [1] - Rongda Photoelectric has made investments in 10 external companies and participated in 7 bidding projects, showcasing its active engagement in business development [2] - The company holds 68 patents and has 2 trademark registrations, reflecting its commitment to innovation and intellectual property [2]

Group 1 - The core viewpoint of the news is that Hubei Kewen Biological Technology Co., Ltd. (回盛生物) has shown significant financial growth in its latest quarterly report, with a total revenue of 399 million yuan, representing a year-on-year increase of 92.96% [1] - The company's net profit attributable to shareholders reached 44.5 million yuan, a remarkable year-on-year growth of 371.23% [1] - The company has a current ratio of 1.420 and a quick ratio of 1.162, indicating a strong liquidity position, while its debt-to-asset ratio stands at 47.97% [1] Group 2 - Hubei Kewen Biological has made investments in 13 companies and participated in 50 bidding projects, showcasing its active engagement in the market [2] - The company holds 115 trademark registrations and 63 patents, reflecting its commitment to intellectual property and innovation [2] - Additionally, the company possesses 47 administrative licenses, indicating its compliance and operational capabilities within the industry [2]

金融界消息 截至2025年7月29日收盘，锦富技术（300128）报收于5.33元，下跌1.84%，换手率2.38%， 成交量30.86万手，成交金额1.65亿元。 通过天眼查大数据分析，苏州锦富技术股份有限公司共对外投资了35家企业，参与招投标项目29次，知 识产权方面有商标信息103条，专利信息31条，此外企业还拥有行政许可11个。 来源：金融界 资金流向方面，今日主力资金净流出2471.12万元，占比成交额15.0%。其中，超大单净流出104.47万 元、占成交额0.63%，大单净流出2366.65万元、占成交额14.37%，中单净流出流入1078.52万元、占成 交额6.55%，小单净流入1392.60万元、占成交额8.45%。 锦富技术最新一期业绩显示，截至2025一季报，公司营业总收入4.51亿元、同比增长16.50%，归属净利 润4978.58万元，同比增长14.97%，扣非净利润5161.53万元，同比增长14.53%，流动比率0.867、速动比 率0.667、资产负债率72.96%。 天眼查商业履历信息显示，苏州锦富技术股份有限公司，成立于2004年，位于苏州市，是一家以从事科 技推广和应用 ...

资金流向方面，今日主力资金净流出2521.48万元，占比成交额14.32%。其中，超大单净流出260.77万 元、占成交额1.48%，大单净流出2260.72万元、占成交额12.84%，中单净流出流出971.82万元、占成交 额5.52%，小单净流入3493.30万元、占成交额19.84%。 通过天眼查大数据分析，安徽华人健康医药股份有限公司共对外投资了18家企业，参与招投标项目33 次，知识产权方面有商标信息156条，专利信息21条，此外企业还拥有行政许可41个。 华人健康最新一期业绩显示，截至2025一季报，公司营业总收入12.67亿元、同比增长14.71%，归属净 利润6122.23万元，同比增长28.15%，扣非净利润5970.20万元，同比增长31.11%，流动比率1.189、速动 比率0.786、资产负债率57.07%。 来源：金融界 金融界消息 截至2025年7月29日收盘，华人健康（301408）报收于14.23元，下跌1.52%，换手率8.3%， 成交量12.38万手，成交金额1.76亿元。 天眼查商业履历信息显示，安徽华人健康医药股份有限公司，成立于2001年，位于合肥市，是一家以从 事零 ...